Show Notes
This week on Fat Science, Dr. Emily Cooper, Mark Wright, and Andrea Taylor talk with pediatric eating disorder specialist Dr. Julie O’Toole (Kartini Clinic) and pediatric obesity expert Dr. Evan Nadler about what childhood obesity really is: a biologic, metabolic disease—not a willpower problem and not a failure of parenting. They explore how excess weight, constant hunger, and disordered eating in kids are often signs of underlying metabolic dysfunction and genetics—and why the old “eat less, move more” advice can do real harm, especially when children are shamed or restricted in the name of “health.”
Key Questions Answered Why is childhood obesity a metabolic disease, not a behavior problem? How are obesity and eating disorders deeply connected instead of opposite extremes? What role do GLP-1 medications play in children—and how do we protect against under-fueling? When should parents suspect genetic drivers like hyperphagia or MC4 mutations? How can medical treatment for obesity actually reduce disordered eating behaviors? When does excess weight become a medical issue requiring metabolic evaluation—not another diet?
Key Takeaways Weight is a symptom. Childhood obesity is often a sign of metabolic dysfunction, not overeating. Obesity & eating disorders overlap. Restriction can trigger disordered eating; disordered eating can worsen obesity. “Eat less, move more” harms. Shame-based approaches delay treatment and increase risk of eating disorders. GLP-1s work metabolically, not just through appetite suppression. Kids still need consistent fueling. Genetics matter. Single-gene differences can drive severe childhood hunger & rapid weight gain. Not treating is harm. Avoiding obesity care violates first, do no harm.
Dr. Cooper’s Actionable Tips If your child is gaining weight or constantly hungry, request metabolic labs (insulin, glucose, lipids, liver, hormones). If the doctor only says “eat less, move more,” ask: “How are we evaluating metabolism and genetics?” On GLP-1s? Monitor for under-fueling (skipped meals, low energy, food anxiety) and intervene promptly.
Notable Quote “Not treating childhood obesity is doing harm. It’s a disease, not a lifestyle choice.” — Dr. Evan Nadler
Links & Resources Podcast Home: Fat Science Website Episodes & Show Archive: Cooper Center Podcast Page Education & Metabolic Resources: coopermetabolic.com/resources Submit a Show Question: [email protected] Email Dr. Cooper Directly: [email protected]
Connect with Our Guests Dr. Evan P. Nadler, MD, MBA – Founder, ProCare Consultants & ProCare TeleHealth Website: obesityexplained.com YouTube Channel: Obesity Explained Dr. Julie K. O’Toole, M.D., M.P.H. – Chief Medical Officer & Founder, Kartini Clinic Website: kartiniclinic.com Books: amazon.com/author/julieotoole
*Fat Science breaks diet myths and advances the science of real metabolic health. No diets. No agendas. Just science that makes you feel better. This episode is informational only and not medical advice.
More from Fat Science
Wondering why weight stalls on treatment? Dr. Emily Cooper explains how the brain defends set points and why eating less stops progress. Dr. Emily Cooper, Mark Wright, and Andrea Taylor answer listener letters from around the world. The conversation addresses why athletic men with a BMI of 27 can still show high visceral fat on a DEXA scan, how medications defend metabolic set points, and why intentional undereating triggers starvation responses. The team also examines global access to metabolic treatments, dual incretin agonists versus single agonists, artificial sweeteners, and how to interpret two-hour insulin and glucose tolerance curves. Key Takeaways Rapid weight reduction without adequate nutrition can cause lean mass loss and trigger metabolic defense mechanisms. Dual incretin therapies stimulate GIP receptors far more than GLP-1 receptors compared to natural human hormones, creating different patient responses. Intentional calorie restriction reduces natural incretin production and can impair metabolic signaling, making mechanical fueling essential. Fasting insulin suppression combined with pre-diabetes indicators can reflect the brain pulling glucose during periods of low carbohydrate intake. Resources Mentioned Diabesity Foundations Course Cooper Center for Metabolism Diabesity Institute Connect with Us Podcast Home:fatsciencepodcast.com Cooper Center for Metabolism:coopermetabolic.com Diabesity Institute: diabesityinstitute.org Resources from Dr. Cooper:coopermetabolic.com/resources Join Our Community:patreon.com/cw/FatSciencePodcast Submit Your Question: [email protected] or [email protected] Fat Science is supported by the Diabesity Institute, a nonprofit dedicated to increasing access to effective, science-based metabolic care. This podcast is for informational purposes only and is not intended as medical advice. Please consult with a qualified healthcare provider for personalized recommendations. Produced by: Podcast Impact Studio https://podcastimpactstudio.com
What do new drug reports really mean for your treatment? Explore groundbreaking updates on potential diabetes and weight-loss drugs from Novo Nordisk and Eli Lilly. Dr. Emily Cooper dives into top-line results, explaining what these findings mean for those struggling with metabolic issues. KEY TAKEAWAYS Understanding the difference between efficacy estimand and treatment policy estimand.
Can metabolic dysfunction be the cause of anxiety?
What's the back-to-school metabolism shift all about?